A sequel to the tale of p25/Cdk5 in neurodegeneration

Burcin Ikiz1, Serge Przedborski

  • 1Department of Neurology, Pathology, and Cell Biology and Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032, USA.

Neuron
|December 17, 2008
PubMed

Insights

The p25/Cyclin-dependent kinase 5 (Cdk5) complex inactivates Histone deacetylase 1 (HDAC-1), causing cell cycle errors and DNA damage. This neurotoxic mechanism in neurons highlights HDAC-1 as a potential therapeutic target for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Dysregulation of p25/Cyclin-dependent kinase 5 (Cdk5) is implicated in neurodegenerative processes.
  • Understanding the molecular mechanisms linking p25/Cdk5 to neuronal dysfunction is crucial.

Purpose of the Study:

  • To elucidate the role of Cdk5 in regulating HDAC-1 activity.
  • To investigate the downstream consequences of p25/Cdk5-mediated HDAC-1 inactivation in neurons.

Main Methods:

  • Biochemical assays to assess Cdk5 kinase activity.
  • Cellular models to study cell cycle regulation and DNA damage.
  • Western blotting and immunofluorescence techniques.

Main Results:

  • Cdk5 was found to inactivate Histone deacetylase 1 (HDAC-1).
  • HDAC-1 inactivation by Cdk5 led to cell cycle deregulation.
  • Accumulation of DNA damage was observed in neurons under these conditions.

Conclusions:

  • The p25/Cdk5 complex plays a critical role in neuronal cell cycle control through HDAC-1 inhibition.
  • This pathway contributes to DNA damage, a hallmark of neurodegeneration.
  • HDAC-1 emerges as a potential therapeutic target for neurodegenerative disorders.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...